| 1 | 0.12% saline | - | - | - | - | [1] 299 299 |
| 2 | 0.9% Isotonic Saline (IS) | - | - | - | - | [1] 299 299 |
| 3 | 0.9% Isotonic Saline (IS), 4mL | - | - | - | - | [1] 299 299 |
| 4 | 0.9% normal saline (control) | - | - | - | - | [1] 299 299 |
| 5 | 0.9% physiological saline | - | - | - | - | [1] 266 266 |
| 6 | 0.9% saline | - | - | - | - | [2] 6 6, 70 |
| 7 | 0.9% sodium chloride (normal saline) | [2] Chloride ion Chloride ion, Sodium chloride (Synonym: Saline Nasal 1 fl oz) | [1] D02056
D02056
| - | - | [1] 6 6 |
| 8 | 6% Hypertonic Saline (HS), 4mL | - | - | - | - | [1] 299 299 |
| 9 | 7% Hypertonic Saline (HS) | - | - | - | - | [1] 299 299 |
| 10 | 7% saline | - | - | - | - | [1] 299 299 |
| 11 | Active Treatment Group 7% Hypertonic Saline | - | - | - | - | [1] 299 299 |
| 12 | Anti-TNF discontinuation: Physiological saline solution | - | - | - | - | [2] 96 96, 97 |
| 13 | Arthroscopy & saline irrigation alone | - | - | - | - | [1] 46 46 |
| 14 | BOTOX 100U in normal saline | [1] Botulinum toxin type A Botulinum toxin type A | [1] D00783
D00783
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 226 226 |
| 15 | BOTOX 200U in normal saline | [1] Botulinum toxin type A Botulinum toxin type A | [1] D00783
D00783
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 226 226 |
| 16 | Control Group 0.9% Isotonic Saline | - | - | - | - | [1] 299 299 |
| 17 | Glycerol/Saline | [1] Glycerin Glycerin (Synonym: Glycerinated Phenol Saline) | [1] D00028
D00028
| - | - | [2] 316 316, 317 |
| 18 | HYPERTONIC SALINE | - | - | - | - | [1] 299 299 |
| 19 | Hypertonic saline (7 %) and isotonic saline (0.9%) | - | - | - | - | [1] 299 299 |
| 20 | Hypertonic saline (7%) | - | - | - | - | [1] 299 299 |
| 21 | Hypertonic saline 6% - | - | - | - | - | [1] 299 299 |
| 22 | Hypertonic Saline 7% | [1] Sodium chloride Sodium chloride (Synonym: Saline Nasal 1 fl oz) | [1] D02056
D02056
| - | - | [1] 299 299 |
| 23 | Hypertonic saline solution | [1] Sodium chloride Sodium chloride (Synonym: Saline Nasal 1 fl oz) | [1] D02056
D02056
| - | - | [1] 299 299 |
| 24 | Infusion of Saline | - | - | - | - | [1] 97 97 |
| 25 | Inhaled 7% hypertonic saline (HS) | - | - | - | - | [1] 299 299 |
| 26 | Inhaled hypertonic saline (7%) | - | - | - | - | [1] 299 299 |
| 27 | Injection of normal saline | - | - | - | - | [1] 6 6 |
| 28 | ISOTONIC SALINE | - | - | - | - | [1] 299 299 |
| 29 | Isotonic saline 0.9% | [1] Sodium chloride Sodium chloride (Synonym: Saline Nasal 1 fl oz) | [1] D02056
D02056
| - | - | [1] 299 299 |
| 30 | IV Deployment Of cSVF In Sterile Normal Saline IV Solution | - | - | - | - | [2] 85 85, 229 |
| 31 | Normal Saline | - | - | - | - | [18] 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 |
| 32 | Normal Saline 0.9% Infusion Solution | - | - | - | - | [1] 22 22 |
| 33 | Normal Saline Enema | - | - | - | - | [1] 97 97 |
| 34 | Normal Saline for Injection | - | - | - | - | [1] 13 13 |
| 35 | Normal saline instillation | - | - | - | - | [1] 226 226 |
| 36 | Normal saline IV, salt tablets | - | - | - | - | [1] 299 299 |
| 37 | Normal saline solution | [1] Sodium chloride Sodium chloride (Synonym: Saline Nasal 1 fl oz) | [1] D02056
D02056
| - | - | [1] 299 299 |
| 38 | Normal saline: | - | - | - | - | [1] 299 299 |
| 39 | Other: Continuation of hypertonic saline (HS) | - | - | - | - | [1] 299 299 |
| 40 | Other: Control group(Normal saline) | - | - | - | - | [1] 97 97 |
| 41 | Other: Discontinuation of hypertonic saline (HS) | - | - | - | - | [1] 299 299 |
| 42 | Other: Inhalable Hypertonic saline 7% | - | - | - | - | [1] 299 299 |
| 43 | Other: Inhalable Hypertonic saline 7% + Hyaluronan 0.1% | [1] Hyaluronic acid Hyaluronic acid | [1] D08043
D08043
| - | - | [1] 299 299 |
| 44 | Other: Intrathecal saline injection | - | - | - | - | [1] 13 13 |
| 45 | Other: IV saline infusion | - | - | - | - | [1] 96 96 |
| 46 | Other: normal saline | - | - | - | - | [4] 13 13, 222, 226, 280 |
| 47 | Other: Normal Saline for injection | - | - | - | - | [1] 84 84 |
| 48 | Other: Saline | - | - | - | - | [8] 2 2, 6, 46, 97, 98, 256, 274, 301 |
| 49 | Other: Saline as a nasal spray | - | - | - | - | [1] 226 226 |
| 50 | Other: Saline solution | - | - | - | - | [1] 67 67 |
| 51 | Other: Saline solution. | - | - | - | - | [1] 67 67 |
| 52 | Other: Sterile Normal Saline (0.9% NaCl) | - | - | - | - | [1] 231 231 |
| 53 | Other: sterile saline | - | - | - | - | [1] 46 46 |
| 54 | Other: Subconjunctival injection of saline | - | - | - | - | [1] 90 90 |
| 55 | Other: Vehicle (D5W or saline) | - | - | - | - | [1] 66 66 |
| 56 | Phosphate-buffered saline | [1] Phosphate ion Phosphate ion | - | - | - | [1] 49 49 |
| 57 | Physiological saline | - | - | - | - | [1] 51 51 |
| 58 | PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj | [1] Amantadine Amantadine | [2] D00777
D00777
,
D07441
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 |
| 59 | Placebo (physiological saline) | - | - | - | - | [2] 43 43, 45 |
| 60 | Ropivacaine plus normal saline | [1] Ropivacaine Ropivacaine | [2] D04048
D04048
,
D08490
| [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 70 70 |
| 61 | Saline | - | - | - | - | [10] 6 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 |
| 62 | Saline 0.9% inhalation solution | - | - | - | - | [1] 299 299 |
| 63 | Saline 0.9% NaCl | - | - | - | - | [1] 235 235 |
| 64 | Saline injection | - | - | - | - | [1] 113 113 |
| 65 | Saline Intranasal Delivery | - | - | - | - | [1] 6 6 |
| 66 | Saline Nasal Mist | - | - | - | - | [1] 127 127 |
| 67 | Saline solution | - | - | - | - | [4] 2 2, 34, 288, 299 |
| 68 | Saline Solution for Injection | - | - | - | - | [1] 19 19 |
| 69 | Sterile Normal Saline (0.9% NaCl) | - | - | - | - | [3] 62 62, 234, 254 |
| 70 | Sterile Normal Saline for Intravenous Use | - | - | - | - | [2] 85 85, 229 |
| 71 | Sterile saline | - | - | - | - | [1] 227 227 |
| 72 | Sterile saline for injection | - | - | - | - | [1] 97 97 |
| 73 | Sterile saline solution | - | - | - | - | [1] 51 51 |
| 74 | Triamcinolone Acetonide and normal saline solution | [1] Triamcinolone Triamcinolone | [5] D00385
D00385
,
D00983
,
D00984
,
D00985
,
D06216
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 70 70 |
| 75 | VX-371 in hypertonic saline | - | - | - | - | [1] 299 299 |
| 76 | VX-371 in saline | - | - | - | - | [1] 299 299 |